CTLT RSI Chart
Last 7 days
-0.8%
Last 30 days
-1.0%
Last 90 days
-4.8%
Trailing 12 Months
72.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 4.1B | 0 | 0 | 0 |
2023 | 4.5B | 4.3B | 4.2B | 4.1B |
2022 | 4.7B | 4.8B | 4.8B | 4.7B |
2021 | 5.9B | 4.0B | 4.2B | 4.5B |
2020 | 2.9B | 5.2B | 5.4B | 5.6B |
2019 | 2.5B | 2.5B | 2.6B | 2.7B |
2018 | 2.4B | 2.5B | 2.5B | 2.5B |
2017 | 2.0B | 2.1B | 2.2B | 2.3B |
2016 | 1.8B | 1.8B | 1.9B | 1.9B |
2015 | 1.8B | 1.8B | 1.8B | 1.8B |
2014 | 1.8B | 1.8B | 1.8B | 1.8B |
2013 | 1.8B | 1.8B | 1.8B | 1.8B |
2012 | 0 | 1.7B | 1.7B | 1.7B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 15, 2024 | gunther scott | sold | -21,749 | 56.2 | -387 | svp, quality & reg. affairs |
Jan 25, 2024 | kreuzburg christa | sold (taxes) | -26,364 | 50.41 | -523 | - |
Jan 16, 2024 | hatzfeld michael | acquired | - | - | 7,908 | chief accounting officer |
Dec 08, 2023 | hopson ricky | sold (taxes) | -9,518 | 37.18 | -256 | pres. clinical dev supply div |
Dec 08, 2023 | maselli alessandro | acquired | - | - | 3,761 | president & ceo |
Dec 08, 2023 | gennadios aristippos | acquired | - | - | 1,505 | group pres. pharma & consumer |
Dec 08, 2023 | hopson ricky | acquired | - | - | 747 | pres. clinical dev supply div |
Dec 08, 2023 | gunther scott | acquired | - | - | 1,023 | svp, quality & reg. affairs |
Dec 08, 2023 | gennadios aristippos | sold (taxes) | -13,645 | 37.18 | -367 | group pres. pharma & consumer |
Dec 08, 2023 | maselli alessandro | sold (taxes) | -71,534 | 37.18 | -1,924 | president & ceo |
Which funds bought or sold CTLT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | National Wealth Management Group, LLC | new | - | 358,966 | 358,966 | 0.28% |
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -27.28 | -614,597 | 6,503,890 | -% |
May 16, 2024 | Tidal Investments LLC | sold off | -100 | -238,084 | - | -% |
May 16, 2024 | COMERICA BANK | reduced | -18.33 | 32,579 | 1,280,620 | 0.01% |
May 16, 2024 | Global Financial Private Client, LLC | unchanged | - | 791 | 3,891 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 0.41 | 3,332,690 | 16,077,800 | 0.02% |
May 16, 2024 | Redwood Investment Management, LLC | sold off | -100 | -633,000 | - | -% |
May 15, 2024 | Mariner, LLC | reduced | -49.22 | -166,986 | 294,320 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -10.56 | 4,990,430 | 45,335,100 | 0.01% |
May 15, 2024 | AMUNDI | reduced | -9.1 | 611,713 | 23,652,800 | 0.01% |
Unveiling Catalent Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Catalent Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 372.2B | 85.6B | 9.67 | 4.35 | ||||
MRK | 332.3B | 61.4B | 144.1 | 5.41 | ||||
AMGN | 167.7B | 29.5B | 44.55 | 5.68 | ||||
PFE | 162.3B | 57.8B | 129.52 | 2.81 | ||||
GILD | 84.4B | 27.4B | 174.21 | 3.07 | ||||
TEVA | 18.4B | 16.0B | -37.29 | 1.15 | ||||
MID-CAP | ||||||||
ALKS | 4.1B | 1.7B | 9.41 | 2.37 | ||||
PRGO | 4.1B | 4.6B | -528.11 | 0.89 | ||||
BHC | 2.5B | 9.0B | -5.45 | 0.28 | ||||
AMPH | 2.1B | 676.2M | 13.75 | 3.14 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.35 | 2.06 | ||||
TXMD | 25.8M | 1.3M | -3.49 | 19.84 | ||||
ACRX | 18.4M | 89.6M | -1.29 | 0.19 | ||||
AGRX | 2.5M | 21.5M | -0.32 | 0.12 | ||||
ACOR | 633.5K | 115.7M | 0 | 0.01 |
Catalent Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 4.9% | 1,074 | 1,024 | 982 | 1,055 | 1,037 | 1,149 | 1,022 | 1,287 | 1,273 | 1,217 | 1,025 | 1,188 | 1,053 | 911 | 846 | 3,094 | 761 | 721 | 665 | 726 | 618 |
Gross Profit | 33.9% | 229 | 171 | 169 | 215 | 180 | 387 | 258 | 462 | 423 | 405 | 324 | 439 | 366 | 298 | 249 | 335 | 239 | 232 | 178 | 257 | 199 |
S&GA Expenses | -14.4% | 214 | 250 | 205 | 217 | 190 | 226 | 196 | 226 | 207 | 228 | 183 | 184 | 173 | 165 | 165 | 157 | 136 | 141 | 143 | 143 | 130 |
EBITDA Margin | 17.4% | -0.25* | -0.30* | -0.22* | -0.02* | 0.06* | 0.16* | 0.16* | 0.17* | 0.18* | 0.22* | 0.23* | 0.22* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 1.5% | -65.00 | -66.00 | -58.00 | -56.00 | -51.00 | -47.00 | -32.00 | -32.00 | -33.00 | -32.00 | -26.00 | -31.50 | -27.00 | -26.00 | -26.00 | -20.40 | -34.40 | -34.90 | -36.30 | -31.00 | -26.40 |
Income Taxes | -37.5% | 15.00 | 24.00 | -38.00 | -67.00 | -55.00 | 33.00 | 3.00 | 17.00 | 35.00 | 18.00 | 10.00 | 39.00 | 85.00 | 21.00 | -15.00 | 24.00 | 9.00 | 13.00 | -6.90 | 9.00 | 11.00 |
Earnings Before Taxes | 52.7% | -86.00 | -182 | -797 | -177 | -282 | 114 | 3.00 | 185 | 176 | 115 | 103 | 222 | 317 | 109 | 67.00 | 179 | 30.00 | 59.00 | -6.80 | 80.00 | 43.00 |
EBT Margin | 14.4% | -0.30* | -0.35* | -0.27* | -0.08* | 0.00* | 0.10* | 0.10* | 0.12* | 0.13* | 0.17* | 0.18* | 0.18* | - | - | - | - | - | - | - | - | - |
Net Income | 51.0% | -101 | -206 | -759 | -110 | -227 | 81.00 | - | 168 | 141 | 97.00 | 93.00 | 183 | 232 | 88.00 | 82.00 | 154 | 21.00 | 46.00 | 0.00 | 71.00 | 32.00 |
Net Income Margin | 10.5% | -0.28* | -0.32* | -0.24* | -0.06* | 0.00* | 0.08* | 0.08* | 0.10* | 0.11* | 0.13* | 0.14* | 0.15* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -444.4% | -62.00 | 18.00 | -154 | 58.00 | -202 | 46.00 | -241 | -166 | -10.00 | -54.00 | 9.00 | -55.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 |
Assets | 6.4% | 10,508 | 9,879 | 9,988 | 10,023 | 10,777 | 10,830 | 11,148 | 10,206 | 10,508 | 10,322 | 10,203 | 10,183 | 9,112 | 8,769 | 8,198 | 7,984 | 7,777 | 7,080 | 6,195 | 6,120 | 6,184 |
Current Assets | 15.6% | 2,917 | 2,523 | 2,570 | 2,614 | 2,692 | 2,738 | 2,919 | 2,699 | 2,917 | 3,025 | 2,974 | 3,931 | 2,918 | 2,775 | 2,519 | 2,356 | 2,293 | 1,746 | 1,301 | 1,267 | 1,396 |
Cash Equivalents | -100.0% | - | 162 | 229 | 209 | 280 | 252 | 442 | 281 | 449 | 786 | 849 | 1,969 | 896 | 988 | 833 | 1,007 | 953 | 608 | 189 | 243 | 345 |
Inventory | -100.0% | - | 742 | 775 | 796 | 777 | 744 | 818 | 732 | 702 | 676 | 688 | 622 | 563 | 528 | 461 | 384 | 324 | 297 | 250 | 251 | 257 |
Net PPE | -100.0% | - | 3,735 | 3,777 | 3,723 | 3,682 | 3,671 | 3,579 | 3,167 | 3,127 | 2,820 | 2,727 | 2,581 | 2,524 | 2,359 | 2,130 | 2,036 | 1,901 | 1,770 | 1,618 | 1,561 | 1,537 |
Goodwill | -100.0% | - | 2,339 | 2,351 | 2,316 | 3,039 | 3,023 | 3,215 | 2,929 | 3,006 | 3,012 | 3,026 | 2,531 | 2,519 | 2,515 | 2,462 | 2,490 | 2,471 | 2,449 | 2,208 | 2,196 | 2,221 |
Liabilities | -8.5% | 5,733 | 6,268 | 6,301 | 6,182 | 6,166 | 6,127 | 6,256 | 5,526 | 5,733 | 5,690 | 5,722 | 5,803 | 4,838 | 4,697 | 4,384 | 4,306 | 4,271 | 4,285 | 3,873 | 3,864 | 3,896 |
Current Liabilities | 9.0% | 1,098 | 1,007 | 1,036 | 1,534 | 1,530 | 1,487 | 1,552 | 969 | 1,098 | 1,046 | 1,045 | 1,096 | 1,196 | 1,139 | 1,024 | 920 | 893 | 917 | 658 | 616 | 671 |
Long Term Debt | -100.0% | - | 4,933 | 4,959 | 4,322 | 4,313 | 4,261 | 4,221 | 4,098 | 4,171 | 4,157 | 4,191 | 4,225 | 3,166 | 3,150 | 2,984 | 2,985 | 2,945 | 2,927 | 2,825 | 2,859 | 2,883 |
Shareholder's Equity | 32.2% | 4,775 | 3,611 | 3,687 | 3,841 | 4,611 | 4,892 | 4,912 | 4,700 | 4,775 | 4,632 | 4,481 | 4,021 | 3,915 | 3,713 | 3,456 | 3,072 | 2,899 | 2,188 | 1,716 | 1,649 | 1,682 |
Retained Earnings | 164.4% | 518 | -804 | -703 | -497 | 262 | 372 | 619 | 518 | 518 | 350 | 209 | 114 | 25.00 | -150 | -377 | -460 | -535 | -681 | -694 | -731 | -723 |
Additional Paid-In Capital | -100.0% | - | 4,769 | 4,742 | 4,724 | 4,701 | 4,697 | 4,686 | 4,674 | 4,649 | 4,630 | 4,615 | 4,234 | 4,205 | 4,186 | 4,161 | 3,901 | 3,818 | 3,261 | 2,759 | 2,755 | 2,757 |
Accumulated Depreciation | -100.0% | - | 1,842 | 1,756 | 1,647 | 1,596 | 1,540 | 1,465 | 1,358 | 1,347 | 1,308 | 1,215 | 1,215 | 1,179 | - | - | - | - | - | - | - | - |
Shares Outstanding | -100.0% | - | 180 | 180 | 180 | 179 | 180 | 180 | 180 | 179 | 179 | 171 | 171 | 171 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | - | - | - | - | 7,900 | - | - | - | 17,710 | - | - | - | 8,200 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -89.3% | 12.00 | 112 | -70.00 | 196 | -64.00 | 214 | -92.00 | 69.00 | 138 | 69.00 | 163 | 134 | 75.00 | 74.00 | 150 | 172 | 122 | 121 | 25.00 | 88.00 | 75.00 |
Share Based Compensation | 6.3% | 17.00 | 16.00 | 19.00 | - | 6.00 | 10.00 | 19.00 | 12.00 | 10.00 | 11.00 | 21.00 | 13.00 | - | - | - | - | - | - | - | - | - |
Cashflow From Investing | 22.1% | -74.00 | -95.00 | -84.00 | -121 | -110 | -608 | -116 | -394 | -191 | -1,132 | -167 | -213 | -82.00 | -203 | -151 | -162 | -465 | -114 | -84.90 | -1,252 | -48.90 |
Cashflow From Financing | 100.0% | - | -14.00 | 98.00 | -51.00 | -25.00 | 523 | 74.00 | 1.00 | -3.00 | -49.00 | 1,082 | -17.00 | 166 | -57.00 | 50.00 | 331 | 773 | -66.00 | -35.80 | 1,284 | -8.70 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.80 | 84.00 | - | 494 | - | - | - | -0.20 |
Consolidated Statements of Operations - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |||
Income Statement [Abstract] | ||||||
Net revenue | $ 1,074.0 | $ 1,037.0 | $ 3,080.0 | $ 3,208.0 | ||
Cost of sales | 845.0 | 857.0 | 2,511.0 | 2,383.0 | ||
Gross margin | 229.0 | 180.0 | 569.0 | 825.0 | ||
Selling, general, and administrative expenses | 214.0 | 190.0 | 669.0 | 612.0 | ||
Goodwill, Impairment Loss | 0.0 | (210.0) | (687.0) | (210.0) | ||
Other Cost and Expense, Operating | 32.0 | 15.0 | 68.0 | 40.0 | ||
Operating earnings | (17.0) | (235.0) | (855.0) | (37.0) | ||
Interest expense, net | 65.0 | 51.0 | 189.0 | 130.0 | ||
Other (income)/expense, net | [1] | 4.0 | (4.0) | 21.0 | (2.0) | |
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total | (86.0) | (282.0) | (1,065.0) | (165.0) | ||
Income tax expense | 15.0 | (55.0) | 1.0 | (19.0) | ||
Net earnings/(loss) | $ (101.0) | $ (227.0) | $ (1,066.0) | $ (146.0) | ||
Earnings Per Share, Basic | $ (0.56) | $ (1.26) | $ (5.87) | $ (0.81) | ||
Earnings Per Share, Diluted | $ (0.56) | $ (1.26) | $ (5.87) | $ (0.81) | ||
|
Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2024 | Jun. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 162.0 | $ 280.0 |
Trade receivables, net | 875.0 | 1,002.0 |
Inventories | 742.0 | 777.0 |
Prepaid expenses and other | 744.0 | 633.0 |
Total current assets | 2,523.0 | 2,692.0 |
Property, plant, and equipment, net | 3,735.0 | 3,682.0 |
Other assets: | ||
Goodwill | 2,339.0 | 3,039.0 |
Other intangibles, net | 875.0 | 980.0 |
Deferred Income Tax Assets, Net | 66.0 | 55.0 |
Other Assets, Noncurrent | 341.0 | 329.0 |
Total assets | 9,879.0 | 10,777.0 |
Current Liabilities: | ||
Debt, Current | 47.0 | 536.0 |
Accounts payable | 377.0 | 424.0 |
Other accrued liabilities | 583.0 | 570.0 |
Total current liabilities | 1,007.0 | 1,530.0 |
Long-term obligations, less current portion | 4,933.0 | 4,313.0 |
Pension liability | 97.0 | 100.0 |
Deferred Income Taxes | 64.0 | 76.0 |
Other liabilities | 167.0 | 147.0 |
Total liabilities | $ 6,268.0 | $ 6,166.0 |
Common Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 |
Common Stock, Shares Authorized | 1,000,000,000 | 1,000,000,000 |
Common Stock, Value, Outstanding | $ 2.0 | $ 2.0 |
Preferred Stock, Value, Outstanding | 0.0 | 0.0 |
Additional paid in capital | 4,769.0 | 4,701.0 |
Accumulated deficit | (804.0) | 262.0 |
Accumulated other comprehensive income/(loss) | (356.0) | (354.0) |
Total shareholders' equity | 3,611.0 | 4,611.0 |
Total liabilities, redeemable preferred stock, and shareholders’ equity | $ 9,879.0 | $ 10,777.0 |
Common stock, shares issued (shares) | 181,000,000 | 180,000,000 |
 | Mr. Alessandro Maselli |
---|---|
 | catalent.com |
 | Pharmaceuticals |
 | 17800 |